|Overdose, the Hungrian wonder horse who survived a long layoff for what was described as laminitis, broke a track record in Germany yesterday. (Photo via Flickr.com's Gabor Dvornik)|
Much of Overdose's successful return to racing had been credited to his American glue-on shoes, made by Sound Horse Technologies, and his British farrier, Stuart Packham who is apparently something of a national hero in Hungary. I don't know if Stuart is still with Overdose, but something is working.
In a race last year, Overdose lost one of his glue-ons during the race but still won. I think that lost shoe was the most famous shoe story in many years!
Stuart Packham's shoeing of Overdose was featured in a step-by-step story in one of the many Hungarian blogs about Overdose. (This is not meant to be an advertisement for the shoes; it is a great photo story for anyone who'd like to see one of these shoes applied.)
The Racing Post, as usual, has more details about yesterday's win. It sounds like he may be headed for Royal Ascot if all goes well. Wouldn't you love to see him against Black Caviar?
© Fran Jurga and Hoofcare Publishing; Fran Jurga's Hoof Blog is a between-issues news service for subscribers to Hoofcare and Lameness Journal. Please, no use without permission. You only need to ask. This blog may be read online at the blog page, checked via RSS feed, or received via a digest-type email (requires signup in box at top right of blog page). To subscribe to Hoofcare and Lameness (the journal), please visit the main site, www.hoofcare.com, where many educational products and media related to equine lameness and hoof science can be found. Questions or problems with this blog? Send email to firstname.lastname@example.org.
Follow the Hoof Blog on Twitter: @HoofcareJournal
Join the Hoofcare + Lameness Facebook Page
Disclosure of Material Connection: I have not received any direct compensation for writing this post. I have no material connection to the brands, products, or services that I have mentioned, other than Hoofcare Publishing. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: Guides Concerning the Use of Endorsements and Testimonials in Advertising.